Peptide record

TPDB05359

Protachykinin-1 Substance P Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier Cell-penetrating Peptides Neuropeptide Toxicity standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05359
Protachykinin-1 Substance P
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier Cell-penetrating Peptides Neuropeptide Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides Neuroactive peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb AI4AVP B3Pred BBPpredict CellPPD-MOD CPPsite3.0 ToxinPred 3.0
standard
No
A 11-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
RPKPQQFFGLM
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C63H97N17O14S1
ANDCEHISTWYV
QFP
1348.63
11.49
2
0
4
+2
1.58
-0.700
35.45
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
0
0.00
2
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
2
Q
1
G
0
H
0
I
1
L
1
K
1
M
2
F
2
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 2 G: 1 H: 0 I: 0 L: 1 K: 1 M: 1 F: 2 P: 2 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
11 reviewed residue count
C63H97N17O14S1 sequence-only estimate (linear, free termini)
1348.63 sequence-only estimate (linear, free termini)
11.49 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
1.58 sequence-only estimate (linear, free termini)
-0.700 sequence-only estimate (linear, free termini)
Evidence Records 23 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5.7 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
It showed a good activity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity agains
Evidence 2 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

vity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity aga
Evidence 3 Activity

Activity

MIC
Antibacterial
171 µg/mL

Target

S. mutans NCTC 10449

Source & Reference

dbAMP DRAMP

Other

k activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity against S. mutans NCTC 10449 (MIC 171 ug/ml).
Evidence 4 Activity

Activity

MIC
Antifungal
5.7 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
It showed a good activity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity agains
Evidence 5 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

vity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity aga
Evidence 6 Activity

Activity

MIC
Antifungal
171 µg/mL

Target

S. mutans NCTC 10449

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

k activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity against S. mutans NCTC 10449 (MIC 171 ug/ml).
Evidence 7 Activity

Activity

MIC
Antiparasitic
5.7 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
It showed a good activity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity agains
Evidence 8 Activity

Activity

MIC
Antiparasitic
8 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

vity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity aga
Evidence 9 Activity

Activity

MIC
Antiparasitic
171 µg/mL

Target

S. mutans NCTC 10449

Source & Reference

DRAMP

Other

k activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity against S. mutans NCTC 10449 (MIC 171 ug/ml).
Evidence 10 Activity

Activity

MIC
Antiviral
5.7 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
It showed a good activity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity agains
Evidence 11 Activity

Activity

MIC
Antiviral
8 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

vity against E. coli ATCC 25922 (MIC 5.7 ug/ml), P. aeruginosa ATCC 27853 (15 ug/ml), and C. albicans (MIC 8 ug/ml), weak activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity aga
Evidence 12 Activity

Activity

MIC
Antiviral
171 µg/mL

Target

S. mutans NCTC 10449

Source & Reference

DRAMP

Other

k activity against L acidophilus NCTC 1723 (MIC 74 ug/ml), and very weak activity against S. mutans NCTC 10449 (MIC 171 ug/ml).
Evidence 13 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Mus musculus
Opioid
Evidence 14 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Rattus norvegicus
Tachykinin
Evidence 15 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Bos taurus
Tachykinin
Evidence 16 Activity

Activity

Neuropeptide

Target

Substance-P receptor Substance-K receptor Neuromedin-K receptor
Homo sapiens Homo sapiens Homo sapiens

Source & Reference

NA
NeuroPepV2

Other

Homo sapiens
Tachykinin
407 398 465
NP10738 NP10746 NP10672 NP10682 NP10738 NP10746 NP10672 NP10682 NP10738 NP10746 NP10672 NP10682
Evidence 17 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Mesocricetus auratus
Tachykinin
Evidence 18 Activity

Activity

Neuropeptide

Target

Substance-P receptor
Mus musculus

Source & Reference

NA
NeuroPepV2

Other

Mus musculus
Tachykinin
407
NP10748
Evidence 19 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Oryctolagus cuniculus
Tachykinin
Evidence 20 Activity

Activity

Neuropeptide

Target

Substance-P receptor
Rattus norvegicus

Source & Reference

NA
NeuroPepV2

Other

Rattus norvegicus
Tachykinin
407
NP10741 NP10742 NP10750
Evidence 21 Activity

Activity

Neuropeptide

Target

Substance-P receptor
Cavia porcellus

Source & Reference

NA
NeuroPepV2

Other

Cavia porcellus
Tachykinin
407
NP10751
Evidence 22 Activity

Activity

Neuropeptide

Source & Reference

NA
NeuroPepV2

Other

Equus caballus
Tachykinin
Evidence 23 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human pulp fibroblasts

Target

Human pulp fibroblasts

Source & Reference

NA
DBAASP
Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. | J Neuroimmunol | 2008
Additional Detail Fields 3 fields
Opioid Tachykinin
407 398 465
NP10738 NP10746 NP10672 NP10682 NP10748 NP10741 NP10742 NP10750 NP10751